ArticleFrontiers in oncology2021

Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma.

Yiyi Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.